NKGN
Adage Capital Partners’s NKGen Biotech, Inc. Common Stock NKGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,350,000
| Closed | -$13.7M | – | 946 |
|
|
2023
Q1 | $13.7M | Hold |
1,350,000
| – | – | 0.03% | 539 |
|
|
2022
Q4 | $13.4M | Hold |
1,350,000
| – | – | 0.03% | 554 |
|
|
2022
Q3 | $13.2M | Hold |
1,350,000
| – | – | 0.03% | 560 |
|
|
2022
Q2 | $13.1M | Hold |
1,350,000
| – | – | 0.03% | 592 |
|
|
2022
Q1 | $13.1M | Hold |
1,350,000
| – | – | 0.02% | 615 |
|
|
2021
Q4 | $13.1M | Hold |
1,350,000
| – | – | 0.02% | 620 |
|
|
2021
Q3 | $13.1M | Buy |
+1,350,000
| New | +$13.1M | 0.03% | 615 |
|